Tracey Mullen is an accomplished entrepreneur and biotech executive with extensive experience in antibody discovery and development. They served as the CEO of Abveris from 2020 to 2022 and held various leadership roles at Biogen, Aeterna Therapeutics, and Twist Bioscience. Currently, Tracey is the Chief Strategy Officer at Mosaic Biosciences, the CEO and Co-Founder of a Stealth Mode Biotech, and an External Advisor at Bain & Company. They earned a Bachelor of Science in Chemical-Biological Engineering from the Massachusetts Institute of Technology and an Executive MBA from the Quantic School of Business and Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices